ACTIMED THERAPEUTICS

actimed-therapeutics-logo

Actimed Therapeutics is a clinical stage biopharmaceutical company focused on bringing innovation to the treatment of muscle wasting disorders to transform the care of an underserved and vulnerable patient population. The company produces anabolic/catabolic transforming agents to treat cachexia, an often deadly syndrome linked with a wide range of chronic illnesses, allowing healthcare providers to manage cancer-related cachexia. Actimed was founded in 2017 by Stefan Anker and Andrew Coats in Ascot, Windsor and Maidenhead.

#SimilarOrganizations #People #Financial #Event #Website #More

ACTIMED THERAPEUTICS

Social Links:

Industry:
Biotechnology Medical Pharmaceutical

Founded:
2017-01-01

Address:
Ascot, Windsor And Maidenhead, United Kingdom

Country:
United Kingdom

Website Url:
http://www.actimedtherapeutics.com

Total Employee:
1+

Status:
Active

Email Addresses:
[email protected]

Total Funding:
23.5 M GBP


Similar Organizations

basilea-pharmaceutica-logo

Basilea Pharmaceutica

Basilea Pharmaceutica Ltd. is a commercial stage biopharmaceutical company.

bioversys-logo

BioVersys

BioVersys is a privately held Swiss biopharmaceutical company.

cerebral-therapeutics-logo

Cerebral Therapeutics

Cerebral Therapeutics is a clinical-stage pharmaceutical company.

context-therapeutics-logo

Context Therapeutics

Context Therapeutics is a clinical-stage biopharmaceutical company.

corvus-pharmaceuticals-logo

Corvus Pharmaceuticals

Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company.

molecular-partners-logo

Molecular Partners

Molecular Partners is a clinical-stage biopharmaceutical company.

peroxitech-therapeutics-logo

Peroxitech Therapeutics

Peroxitech Therapeutics operates as a biopharmaceutical company.

trevarx-biomedical-logo

Trevarx Biomedical

Trevarx Biomedical is a biomedical startup that develops new radiopharmaceuticals.


Current Advisors List

atish-majumdar_image

Atish Majumdar Board Member @ Actimed Therapeutics
Board_member
2023-01-01

Current Employees Featured

robin-bhattacherjee_image

Robin Bhattacherjee
Robin Bhattacherjee Chief Executive Officer @ Actimed Therapeutics
Chief Executive Officer
2019-08-01

frank-misselwitz_image

Frank Misselwitz
Frank Misselwitz Chief Medical Officer and Member Board Of Directors @ Actimed Therapeutics
Chief Medical Officer and Member Board Of Directors
2018-01-01

andrew-coats_image

Andrew Coats
Andrew Coats Founder and Non-Executive Director @ Actimed Therapeutics
Founder and Non-Executive Director

stefan-d-anker_image

Stefan D. Anker
Stefan D. Anker Co-Founder and Chair of Scientific Advisory Board @ Actimed Therapeutics
Co-Founder and Chair of Scientific Advisory Board

Founder


andrew-coats_image

Andrew Coats

stefan-d-anker_image

Stefan D. Anker

Investors List

mankind-pharma_image

Mankind Pharma

Mankind Pharma investment in Series A - Actimed Therapeutics

mankind-pharma_image

Mankind Pharma

Mankind Pharma investment in Series A - Actimed Therapeutics

mankind-pharma_image

Mankind Pharma

Mankind Pharma investment in Seed Round - Actimed Therapeutics

Key Employee Changes

Date New article
2023-10-19 Actimed Therapeutics Appoints Martin Walton as Chief Financial Officer

Official Site Inspections

http://www.actimedtherapeutics.com

  • Host name: s20998836.onlinehome-server.info
  • IP address: 217.160.183.146
  • Location: Germany
  • Latitude: 51.2993
  • Longitude: 9.491
  • Timezone: Europe/Berlin

Loading ...

More informations about "Actimed Therapeutics"

Actimed - About us

About Actimed Therapeutics. Actimed Therapeutics. We are focused on bringing innovation to the treatment of cachexia with a vision to transform care for an under-served and vulnerable โ€ฆSee details»

Actimed Therapeutics - Crunchbase Company Profile

Contact Email [email protected] Actimed Therapeutics is a clinical stage biopharmaceutical company focused on bringing innovation to the โ€ฆSee details»

Actimed Therapeutics Company Profile 2024: โ€ฆ

Information on valuation, funding, cap tables, investors, and executives for Actimed Therapeutics. Use the PitchBook Platform to explore the full profile.See details»

Board - Actimed

Meet the board of Actimed Therapeutics. Andrew J. Stewart Coats, Founder and Non-Executive Director Professor Andrew Coats MBA, DSc, DM, co-founded Actimed Therapeutics in 2017, โ€ฆSee details»

ACTIMED THERAPEUTICS - LinkedIn

Actimed is pleased to have received orphan drug designation for S-oxprenolol (ACM-002) in amyotrophic lateral sclerosis (ALS), a devastating orphan disease of high, unmet medical โ€ฆSee details»

ACTIMED THERAPEUTICS: Contact Details and Business Profile

Actimedtherapeutics.com; View Similar People. Related Companies Peppy. 171 $5.3m Plus-Project Partnership. 79 $1m Business in Wales. 111 NRS Healthcare. 21 $127m Numan. 239 โ€ฆSee details»

Actimed Therapeutics - VentureRadar

Website: https://actimedtherapeutics.com/ Develops innovative treatments for muscle wasting disorders, focusing on cachexia associated with cancer and chronic ...See details»

Member profile: Actimed Therapeutics | BIA - BioIndustry

Actimed Therapeutics is a clinical stage biopharmaceutical company focused on bringing innovation to the treatment of muscle wasting disorders to transform the care of an โ€ฆSee details»

Actimed Therapeutics - Craft

Actimed Therapeutics is a clinical-stage company that focuses on the treatment of muscle wasting disorders. It develops ACM-001 (S-pindolol) which is in clinical development for cancer-related โ€ฆSee details»

Actimed Therapeutics Ltd. (Actimed Therapeutics Ltd.) - ่ฏ็‰ฉ็ฎก็บฟ_ โ€ฆ

London, UK โ€“ 13th December 2024. Actimed Therapeutics Ltd (โ€œActimedโ€), a UK based clinical stage speciality pharmaceutical company focused on bringing innovation to the treatment of โ€ฆSee details»

Actimed Therapeutics - Products, Competitors, Financials, โ€ฆ

Actimed Therapeutics Announces Professor David Ebsworth to Become Executive Chairman. Nov 14, 2024. Professor David Ebsworth to work closely alongside CEO Robin Bhattacherjee Will โ€ฆSee details»

Actimed Therapeutics secures additional £4.75m funding in

Aug 22, 2023 www.actimedtherapeutics.com MEDiSTRAVA Consulting Frazer Hall, Evelyn McCormack Tel: +44 (0)203 928 6900 Email: [email protected]. WG Partners LLP โ€ฆSee details»

Actimed Therapeutics announces FDA approval of its โ€ฆ

Sep 7, 2023 www.actimedtherapeutics.com. MEDiSTRAVA Consulting Frazer Hall, Erica Hollingsworth Tel: +44 (0)203 928 6900 Email: [email protected]. WG Partners LLP โ€ฆSee details»

Actimed Therapeutics - Overview, News & Similar companies

Dec 18, 2023 Popular Searches Actimed Therapeutics Ltd Actimed Therapeutics Acti-med Inc ActimedTherapeutics SIC Code 28,283 NAICS Code 32,325 Show more. Similar Companies โ€ฆSee details»

Actimed Therapeutics Company Information - Funding, Investors, โ€ฆ

Track over 23,965 companies. Discover Fast-growing Global startups. Seedtable uses technology and people to track over 23,965 companies to help you find the right ones to partner with.See details»

Actimed Therapeutics announces FDA approval of its

Sep 7, 2023 www.actimedtherapeutics.com MEDiSTRAVA Consulting Frazer Hall, Erica Hollingsworth Tel: +44 (0)203 928 6900 Email: [email protected]. WG Partners LLP โ€ฆSee details»

Actimed Therapeutics closes over-subscribed Series A

Jun 26, 2023 www.actimedtherapeutics.com. MEDiSTRAVA Consulting Frazer Hall, Evelyn McCormack Tel: +44 (0)203 928 6900 Email: [email protected]. WG Partners LLP โ€ฆSee details»

Actimed - Actimed Therapeutics Continues to Strengthen โ€ฆ

London, UK โ€“ 13 October, 2021. Actimed Therapeutics Ltd, the clinical stage company focused on bringing innovation to the treatment of muscle wasting disorders, with a focus on cachexia, โ€ฆSee details»

Actimed - Pipeline Overview

Detail of our pipeline for treating cachexia. Our small-molecule programme, led by S-pindolol benzoate (ACM-001.1), consists of multi-action agents that affect more than one pathway โ€ฆSee details»

linkstock.net © 2022. All rights reserved